All News about Mainz Biomed N.V. - Ordinary SharesVia Benzinga
From Mainz BioMed NV
Via GlobeNewswire
Via Benzinga
Outdoing Cancer Requires Pharma To Go Beyond Merely Revolutionizing Existing Treatment
February 22, 2024
Via Benzinga
Topics
Intellectual Property
From Mainz BioMed NV
Via GlobeNewswire
Via Benzinga
Pfizer Surprises With Profit But Revolutionizing Cancer Treatment Is Its Best Chance Of Getting Back In The Saddle
February 01, 2024
Via Benzinga
Exposures
COVID-19
2 Million Cancer Diagnoses And 600,000 Cancer Deaths Expected In 2024 – Prevention Is Key To Treatment, And Mainz Biomed Is Leading The Charge
February 01, 2024
Via Benzinga
Topics
Death
Exposures
Death
Mainz Biomed Provides Year-End Corporate Review 2023
January 09, 2024
From Mainz BioMed NV
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|